Systemic complement activation levels in Stargardt disease

PURPOSE: Preclinical research provides evidence for the complement system as a potential common pathway in Stargardt disease (STGD1) and age-related macular degeneration (AMD) leading to retinal pigment epithelium (RPE) loss. However, systemic complement activation has not yet been assessed in STGD1...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhooge, Patty P. A., Runhart, Esmee H., Li, Catherina H. Z., de Kat Angelino, Corrie M., Hoyng, Carel B., van der Molen, Renate G., den Hollander, Anneke I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232401/
https://www.ncbi.nlm.nih.gov/pubmed/34170959
http://dx.doi.org/10.1371/journal.pone.0253716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232401/
https://www.ncbi.nlm.nih.gov/pubmed/34170959
http://dx.doi.org/10.1371/journal.pone.0253716

Ejemplares similares